Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Bristol-Myers Squibb Company Ce

CELG-RI•NYSE
Healthcare
Drug Manufacturers - General
$0.09
$0.00(0.00%)
U.S. Market is Open • 12:58

Bristol-Myers Squibb Company Ce (CELG-RI) Stock Overview

Explore Bristol-Myers Squibb Company Ce’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap163.3M
P/E Ratio0.03
EPS (TTM)N/A
ROE0.39%
Fundamental Analysis

AI Price Forecasts

1 Month$0.09
3 Months$0.09
1 Year Target$0.08

CELG-RI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bristol-Myers Squibb Company Ce (CELG-RI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 43.71, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.08.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.03 and a market capitalization of 163.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-10.89%
5-Day Change
-18.99%
1-Month Change
-52.82%
3-Month Change
197.04%
6-Month Change
130.46%
Year-to-Date (YTD) Change
0.66%
1-Year Change
35.93%
3-Year Change
-45.22%
5-Year Change
-48.22%
All-Time (Max) Change
-48.22%

Contact Information

http://www.bms.com
Princeton, DE

Company Facts

34,100 Employees
CountryUS
Actively Trading

Frequently Asked Questions